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therapy is available to HSCT patients as a weekly group
session, incorporated in an existing exercise class three times
a week, or on an individual consult basis.
Evaluation: At the end of each week, participants in music
therapy are asked to complete a short survey on their
perceptions of the effects of the therapy on a number of
factors, including stress, anxiety, sleep, comfort, pain and
others. Results will be used to reﬁne the program and
potentially lead to nursing research.
Discussion: Music therapy has been reported to reduce pain
and depression, promote rest and relaxation, and enhance
patient satisfaction. Given the complexities involved in
hematopoietic stem cell transplantation, interdisciplinary
collaboration between nurses and music therapists can
support the integration of music therapy to enhance patient
care outcomes and promote patient satisfaction.Figure 1.303
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Voriconazole has been increasingly used in the treatment of
invasive aspergillosis and for antifungal prophylaxis after
allogeneic BMT. The incidence of drug-induced skin reactions
is estimated to be 7%. There is a growing awareness of the
higher risk of acute and cumulative phototoxicity, and the
risk of chronic photo-damage and non-melanoma sun-
related skin cancers in immunocompromised patients.
Between August 2009 and June 2012, 40 of 43 consecutive
allo-BMT recipients (mean age 9.8 y; 83% Caucasian) received
voriconazole prophylaxis [7 mg/kg/dose BID (12 yrs age);
200 mg BID (>12 yrs); adjusted to target trough 1.0 mg/
mL]. Nine of forty (22.5%) patients, all Caucasian, developed
skin rashes in sun-exposed distributions during spring-
summer season. The average prior voriconazole exposure
was 6months (1.8e12.5mo). Dermatologic ﬁndings included
1) diffuse sunburn-like erythema over the face, outer aspects
of forearm, and hands 2) linear papulovesicular lesions 3)
severe bullous cheilitis (Figure 1) dermatoheliosis and 5)
lentigines. Voriconazole was continued in four, substituted
with ﬂuconazole in four and with posaconazole in one
patient. Patients were treated with sun avoidance, high-
potency sun-screens, and topical steroids with signiﬁcant
improvement in all cases.All (40) No Phototoxic
rash (31)
Phototoxic
rash (9)
Mean Vori- level (mg/ml) 1.3 1.2 1.5
Mean -N oxide (mg/ml) 3.5 3.2 4.8While trough voriconazole plasma concentrations do not
appear to be different, N-oxide metabolite concentrations
were higher in photosensitive patients.Signiﬁcant higherincidence of photosensitivity occurs in voriconazole-treated
children, especially Caucasians, during prolonged drug use
and intense sunshine. Voriconazole N-oxide may act as
a chromophore for phototoxicity, and its potential role in
individual susceptibility should be explored. Voriconazole
may be continued, although change to other azoles may be
necessary in some patients. Prolonged voriconazole use
requires close monitoring for chronic skin toxicities. Long-
term risks including the risk of skin cancer need to be
investigated.304
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Background: Although improvement of supportive cares
including antimicrobial prophylaxis has signiﬁcantly
ameliorated treatment outcomes in patients with hemato-
poietic stem cell transplantation (HSCT), bacterial blood-
stream infection (BSI) is still a major cause of morbidity and
mortality of HSCT. The purpose of this study is to evaluate
pre-transplant risk factors of BSI after HSCT and compare the
nature of BSIs between allogenic and autologous HSCT.
Methods: Adult patients (age  18 years) who received
either allogenic or autologous HSCT in a single institution
between November 2002 and June 2012, were analyzed.
Report of blood cultures from the start time of conditioning
therapy to hospital discharge, and clinical relevance of the
BSIs, were reviewed. Evaluated potential risk factors of BSI
were type of HSCT (allogenic vs. autologous), age, gender,
disease (AML vs. others), time from diagnosis to HSCT,
amount of infused CD34+ stem cell, HCT-CI score, and use of
antibiotics from conditioning for prophylactic or therapeutic
intent. Blood level of C-reactive protein (CRP), albumin, and
ferritin within 14 days from HSCT were also included in the
analysis. Among patients with allogenic HSCT, modiﬁed
EBMT score, concomitant acute GVHD, type of donor and
intensity of conditioning were additionally evaluated.
